Description

FORAHALE-200 Inhacaps: Advanced Dual-Action Respiratory Therapy

Product Range: Inspicare (Respiratory Division)

Composition: Formoterol Fumarate Dihydrate 6 mcg + Budesonide 200 mcg

Format: Dry Powder Inhalation (DPI) Capsules (For use with a specialized Inhaler: Inspihaler)

Product Overview

FORAHALE-200 Inhacaps is a potent combination therapy designed for the long-term maintenance and management of obstructive airway diseases. By integrating an Inhaled Corticosteroid (ICS) with a Long-Acting Beta2-Agonist (LABA), Forahale-200 provides a comprehensive approach to respiratory health. It addresses both the underlying inflammation and the physical constriction of the airways, allowing patients to breathe more freely and significantly reducing the frequency of exacerbations.

Mechanism of Action: The Synergy of Control and Relief

Forahale-200 works through a dual-mechanism pathway to ensure optimal lung function:

• Budesonide (200 mcg): A potent glucocorticoid that exerts a direct anti-inflammatory effect on the bronchial mucosa. It reduces the swelling and irritation of the airway walls, decreases mucus production, and lowers the hyper-responsiveness of the lungs to environmental triggers.
• Formoterol (6 mcg): A selective LABA that provides rapid-onset (within 1–3 minutes) and long-lasting (up to 12 hours) bronchodilation. It works by relaxing the smooth muscles of the airways, ensuring they remain open for extended periods.
• The “Inhacap” Advantage: As a Dry Powder Inhalation (DPI), the medication is delivered directly to the lungs with a single inspiratory breath, minimizing systemic side effects and ensuring the drug reaches the deep alveolar tissues where it is needed most.

Key Benefits

• Rapid & Sustained Relief: Unlike many other maintenance therapies, the Formoterol in Forahale starts working almost as fast as a rescue inhaler but lasts significantly longer.
• Reduced Flare-ups: Regular use helps prevent the “attacks” or “exacerbations” that often lead to emergency room visits.
• Improved Quality of Life: Reduces symptoms of wheezing, chest tightness, and shortness of breath, allowing patients to remain active.
• Targeted Delivery: Inhacaps provide precise dosing with minimal coordination required compared to traditional pressurized MDIs.

Key Indications & Uses:

• Asthma: For the regular treatment of asthma where the use of a combination (bronchodilator and inhaled corticosteroid) is appropriate.
• Chronic Obstructive Pulmonary Disease (COPD): For the symptomatic treatment of patients with severe COPD and a history of repeated exacerbations.

Dosage

• Adults and Adolescents (12 years and older): 1–2 Inhacaps twice daily.
• Maximum Dose: Not to exceed 4 Inhacaps per day.

The dose should be titrated to the lowest dose at which effective control of symptoms is maintained.

⚠️ DISCLAIMER: This product is for the prescription by Registered Medical Practitioners or Hospitals only. It must be taken strictly under the supervision and advice of a registered medical practitioner. Do not self-medicate.

Clinical Advantages of FORAHALE-200

• Enhanced Compliance: The 12-hour duration of action allows for convenient twice-daily dosing, fitting easily into a patient’s routine.
• Safety Profile: Budesonide has a high first-pass metabolism, meaning any drug swallowed is quickly broken down by the liver, reducing the risk of systemic steroid-related side effects.
• Stability: Dry powder formulations are generally more stable and less temperature-sensitive than aerosol-based inhalers.

Why FORAHALE-200?

Within the Inspicare division, Forahale-200 is a cornerstone product for respiratory specialists.

• High Prescription Volume: Asthma and COPD are chronic conditions requiring long-term, daily therapy, ensuring consistent and high-volume demand.
• Specialty Segment Growth: With rising pollution levels and respiratory sensitivities, the market for effective ICS+LABA combinations is growing rapidly.
• Trust & Reliability: The Inspicare name is synonymous with high-quality respiratory care, making it a preferred brand for Chest Physicians and Pulmonologists.

“Breath by breath, restoring the rhythm of life. FORAHALE-200—The reliable choice for clear airways and confident living.”

India PCD Pharma Business Partnership Opportunity

Partner with Best Biotech: Breathe New Life into Your Pharma Business

Are you looking to lead the respiratory segment in your region? The Inspicare division—powered by Best Biotech—is expanding its franchise network. We invite dedicated pharma professionals to join us through our Pharma PCD and Franchise models, offering exclusive rights to our premium respiratory portfolio, including leaders like Forahale-200.

With ISO-certified manufacturing and dedicated marketing support, we help you build a successful enterprise centred on quality and care. Connect with us today to secure your territory.

Quick Links:

1. TASTIRON-XT SYRUP: Dosage, Uses & Product Information
2. Can Less ‘Sun-Time’ Drive High Blood Pressure?
3. Why Your Acid Reflux is Not Improving With Medicines? What Can Be Done?
4. Can WIKLYONE (Trelagliptin) Reduce the Diabetes Burden in India?
5. The True Monthly Cost of Diabetes Pills: Is Your Daily Regimen Costing You More?
6. Join us on WhatsApp for instant updates.